SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 9.61 |
| Enterprise Value ($M) | 31.94 |
| Book Value ($M) | 15.58 |
| Book Value / Share | 1.69 |
| Price / Book | 0.62 |
| NCAV ($M) | -6.24 |
| NCAV / Share | -0.68 |
| Price / NCAV | -1.54 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.75 |
| Return on Assets (ROA) | -0.83 |
| Return on Equity (ROE) | -26.65 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.36 |
| Current Ratio | 1.84 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 36.64 |
| Assets | 58.47 |
| Liabilities | 42.88 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Iliad Research & Trading, L.P. | 9.13 | 102.12 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 41,750 | 176,594 | 23.64 | |
| 128,561 | 244,958 | 52.48 | |
| 29,956 | 96,772 | 30.96 | |
| 53,005 | 129,392 | 40.96 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| INTS – Intensity Therapeutics, Inc. | IRD – Opus Genetics, Inc. |
| ITRM – Iterum Therapeutics plc | JSPR – Jasper Therapeutics, Inc. |
| KALA – KALA BIO, Inc. |
Financial data and stock pages provided by
Fintel.io